Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FEHYC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $215,143
Award facts
- Contract value 100% obligated
- $215,142.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $215,142.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pre-filled pens on September 23, 2025, with a completion date of September 24, 2025. This is a non-set-aside competitive award for pharmaceutical delivery to the place of performance in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. This award of Cosentyx, a biologic immunosuppressant used for autoimmune conditions, reflects AmerisourceBergen's role in supporting military and veteran healthcare systems through the DLA's pharmaceutical prime vendor programs.
Quick answers
Who was awarded contract SPE2DB25FEHYC?
SPE2DB25FEHYC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 23, 2025.
How much is contract SPE2DB25FEHYC worth?
The government has obligated $215,143 on SPE2DB25FEHYC.
Is contract SPE2DB25FEHYC an order under another contract?
Yes. SPE2DB25FEHYC is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB25FEHYC competed?
The extent of competition for SPE2DB25FEHYC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award